Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Tada

Showing results (221-230 of 258) with videos related to

Pageof 26
Sort By:
Investigational New Drugs|October 7, 2010
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabineTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|July 5, 2014
Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstructionTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 17, 2013
Two cases with hepatic amyloidosis suspected of having primary sclerosing cholangitisKenji Hirano, Masako Ikemura, Suguru Mizuno, et al.
Gut and Liver|December 7, 2013
A novel, fully covered laser-cut nitinol stent with antimigration properties for nonresectable distal malignant biliary obstruction: a multicenter feasibility studyHiroyuki Isayama, Kazumichi Kawakubo, Yousuke Nakai, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 20, 2019
Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitusSuguru Mizuno, Hiroyuki Isayama, Yousuke Nakai, et al.
Investigational New Drugs|November 10, 2018
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancerKei Saito, Hiroyuki Isayama, Yousuke Nakai, et al.
Oncology|June 17, 2011
Gemcitabine and oxaliplatin combination chemotherapy for patients with refractory pancreatic cancerHiroyuki Isayama, Yousuke Nakai, Keisuke Yamamoto, et al.
Journal of Gastroenterology|June 28, 2012
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset ageSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pancreas|November 14, 2012
High alcohol consumption increases the risk of pancreatic stone formation and pancreatic atrophy in autoimmune pancreatitisKenji Hirano, Minoru Tada, Hiroyuki Isayama, et al.
Pancreas|July 1, 2014
Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patientsSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pageof 26

Showing results (221-230 of 258) with videos related to

Sort By:
Pageof 26
Investigational New Drugs|October 7, 2010
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabineTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|July 5, 2014
Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstructionTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 17, 2013
Two cases with hepatic amyloidosis suspected of having primary sclerosing cholangitisKenji Hirano, Masako Ikemura, Suguru Mizuno, et al.
Gut and Liver|December 7, 2013
A novel, fully covered laser-cut nitinol stent with antimigration properties for nonresectable distal malignant biliary obstruction: a multicenter feasibility studyHiroyuki Isayama, Kazumichi Kawakubo, Yousuke Nakai, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 20, 2019
Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitusSuguru Mizuno, Hiroyuki Isayama, Yousuke Nakai, et al.
Investigational New Drugs|November 10, 2018
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancerKei Saito, Hiroyuki Isayama, Yousuke Nakai, et al.
Oncology|June 17, 2011
Gemcitabine and oxaliplatin combination chemotherapy for patients with refractory pancreatic cancerHiroyuki Isayama, Yousuke Nakai, Keisuke Yamamoto, et al.
Journal of Gastroenterology|June 28, 2012
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset ageSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pancreas|November 14, 2012
High alcohol consumption increases the risk of pancreatic stone formation and pancreatic atrophy in autoimmune pancreatitisKenji Hirano, Minoru Tada, Hiroyuki Isayama, et al.
Pancreas|July 1, 2014
Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patientsSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pageof 26